Teva Plans To Appeal EU Provigil Fine

Teva And Cephalon Affiliate Fined €60.5m Over ‘Pay-For-Delay’ Deal

 
• By Dean Rudge

Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).

GavelEuros
Teva insists the settlement agreement did not infringe EU competition law in relation to principles laid out by the ECJ • Source: Shutterstock

More from Deals

More from Business